Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

322 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proposing new lipoprotein (a) cut off value for Kazakhstan: pilot study.
Bekbossynova M, Aripov M, Ivanova-Razumova T, Kali A, Tleubayeva D, Daniyarova G, Goncharov A. Bekbossynova M, et al. Among authors: kali a. Front Cardiovasc Med. 2024 Oct 21;11:1468566. doi: 10.3389/fcvm.2024.1468566. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39498354 Free PMC article.
Venetoclax in combination with fludarabine, cytarabine, granulocyte colony stimulating factor, and idarubicin (FLAG-Ida) in patients with acute leukemia of ambiguous lineage and acute lymphoblastic leukemia.
Tessier S, McCullough KB, Gangat N, Begna KH, Saliba AN, Mangoankar AA, Shah MV, Hogan WJ, Patnaik MM, Al-Kali A, Alkhateeb HB. Tessier S, et al. Among authors: al kali a. Leuk Lymphoma. 2025 Jan 16:1-5. doi: 10.1080/10428194.2024.2443017. Online ahead of print. Leuk Lymphoma. 2025. PMID: 39817316 No abstract available.
Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent.
Gangat N, Elbeih A, Ghosoun N, McCullough K, Aperna F, Johnson IM, Abdelmagid M, Al-Kali A, Alkhateeb HB, Begna KH, Elliott M, Mangaonkar A, Matin A, Saliba AN, Hefazi Torghabeh M, Litzow MR, Hogan W, Shah M, Patnaik MM, Pardanani A, Badar T, Murthy H, Foran J, Palmer J, Sproat L, Khera N, Arana Yi C, Yates S, Sneider A, Dworkin E, Patel AA, Bazinet A, Senapati J, Bataller A, DiNardo C, Kadia T, Tefferi A. Gangat N, et al. Among authors: al kali a. Am J Hematol. 2025 Feb;100(2):260-271. doi: 10.1002/ajh.27564. Epub 2024 Dec 13. Am J Hematol. 2025. PMID: 39671248 Free PMC article.
Venetoclax in combination with hypomethylating agents in chronic myelomonocytic leukemia: a propensity score matched multicenter cohort study.
Tremblay D, Csizmar C, DiNardo CD, Ball S, Rippel N, Hammond D, Kadia TM, Ravandi F, Chien K, Van Hyfte G, Mazumdar M, Saliba A, Mangaonkar A, Lasho T, Al-Kali A, Kremyanskaya M, Feld J, Silverman LR, Komrokji R, Mascarenhas J, Padron E, Garcia-Manero G, Sallman DA, Patnaik MM, Montalban-Bravo G. Tremblay D, et al. Among authors: al kali a. Leukemia. 2025 Jan;39(1):257-260. doi: 10.1038/s41375-024-02466-6. Epub 2024 Nov 12. Leukemia. 2025. PMID: 39533069 No abstract available.
Clinical outcomes of patients diagnosed with SETBP1 mutated myeloid neoplasms.
Jabban Y, Yacout M, Baranwal A, He R, Viswanatha D, Greipp P, Jevremovic D, Bessonen K, Foran J, Palmer J, Saliba AN, Hefazi-Torghabeh M, Begna K, Hogan WJ, Mangaonkar A, Patnaik M, Shah M, Alkhateeb H, Al-Kali A. Jabban Y, et al. Among authors: al kali a. Leuk Lymphoma. 2024 Nov 6:1-10. doi: 10.1080/10428194.2024.2425048. Online ahead of print. Leuk Lymphoma. 2024. PMID: 39504138
PHF6 mutations in chronic myelomonocytic leukemia identify a unique subset of patients with distinct phenotype and superior prognosis.
Tefferi A, Fathima S, Alsugair AKA, Aperna F, Natu A, Abdelmagid MG, Csizmar CM, Gurney M, Lasho TL, Finke CM, Mangaonkar AA, Al-Kali A, Pardanani A, Reichard KK, He R, Gangat N, Patnaik MM. Tefferi A, et al. Among authors: al kali a. Am J Hematol. 2024 Dec;99(12):2321-2327. doi: 10.1002/ajh.27492. Epub 2024 Sep 27. Am J Hematol. 2024. PMID: 39329442
Characterisation and prognostic impact Of ZRSR2 mutations in myeloid neoplasms.
Yacout M, Katamesh B, Jabban Y, He R, Viswanatha D, Jevremovic D, Greipp P, Bessonen K, Palmer J, Foran J, Saliba A, Hefazi-Torghabeh M, Begna K, Hogan W, Patnaik M, Shah M, Alkhateeb H, Al-Kali A. Yacout M, et al. Among authors: al kali a. Leukemia. 2024 Dec;38(12):2727-2730. doi: 10.1038/s41375-024-02374-9. Epub 2024 Sep 23. Leukemia. 2024. PMID: 39313565 Free PMC article. No abstract available.
322 results